Biohit Financial Statements From 2010 to 2024
| BIOBV Stock | EUR 2.29 0.03 1.33% |
Check Biohit Oyj financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biohit Oyj's main balance sheet or income statement drivers, such as , as well as many indicators such as . Biohit financial statements analysis is a perfect complement when working with Biohit Oyj Valuation or Volatility modules.
Biohit |
Biohit Oyj B Company Operating Margin Analysis
Biohit Oyj's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Biohit Oyj Operating Margin | 0.1 % |
Most of Biohit Oyj's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biohit Oyj B is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Biohit Oyj B has an Operating Margin of 0.096%. This is 100.27% lower than that of the Health Care Equipment & Supplies sector and 100.09% lower than that of the Health Care industry. The operating margin for all Finland stocks is 101.74% lower than that of the firm.
Biohit Oyj B Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biohit Oyj's current stock value. Our valuation model uses many indicators to compare Biohit Oyj value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biohit Oyj competition to find correlations between indicators driving Biohit Oyj's intrinsic value. More Info.Biohit Oyj B is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 1.01 of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value Biohit Oyj by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biohit Oyj's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Biohit Oyj Financial Statements
Investors use fundamental indicators, such as Biohit Oyj's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biohit Oyj's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Biohit Oyj, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. The company was founded in 1988 and is headquartered in Helsinki, Finland. Biohit Oyj operates under Healthcare Services classification in Finland and is traded on Helsinki Exchange. It employs 49 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biohit Stock
Biohit Oyj financial ratios help investors to determine whether Biohit Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biohit with respect to the benefits of owning Biohit Oyj security.